| 4A4 | | Name: | N/A4-O-[2-(ACETYLAMINO)-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL]-BETA-D-GALACTOPYRANOSE | Formula: | C14 H25 N O11 | SMILES: | O=C(NC2C(O)C(O)C(OC2OC1C(OC(O)C(O)C1O)CO)CO)C | InChi: | InChI=1S/C14H25NO11/c1-4(18)15-7-9(20)8(19)5(2-16)25-14(7)26-12-6(3-17)24-13(23)11(22)10(12)21/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8-,9-,10-,11-,12+,13-,14-/m1/s1 | Definition date: | 2011-10-06 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 4-O-[2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl]-beta-D-galactopyranose |
|
| AW6 | | Name: | 4-chloro-N-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)benzene-1-sulfonamide | Formula: | C20 H12 Cl N O6 S | SMILES: | N(S(=O)(=O)c1ccc(cc1)Cl)c4cc3C(c2ccccc2C(c3c(c4O)O)=O)=O | InChi: | InChI=1S/C20H12ClNO6S/c21-10-5-7-11(8-6-10)29(27,28)22-15-9-14-16(20(26)19(15)25)18(24)13-4-2-1-3-12(13)17(14)23/h1-9,22,25-26H | Definition date: | 2018-11-27 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 4-chloro-N-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)benzene-1-sulfonamide |
|
| B0C | | Name: | N-[3-(4,5-diethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-4-propoxyphenyl]-2-(4-methylpiperazin-1-yl)acetamide | Formula: | C24 H35 N5 O3 | SMILES: | N1(CCN(C)CC1)CC(Nc2ccc(c(c2)C3=NC(CC)=C(CC)C(N3)=O)OCCC)=O | InChi: | InChI=1S/C24H35N5O3/c1-5-14-32-21-9-8-17(25-22(30)16-29-12-10-28(4)11-13-29)15-19(21)23-26-20(7-3)18(6-2)24(31)27-23/h8-9,15H,5-7,10-14,16H2,1-4H3,(H,25,30)(H,26,27,31) | Definition date: | 2018-12-13 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-[3-(4,5-diethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-4-propoxyphenyl]-2-(4-methylpiperazin-1-yl)acetamide |
|
| KHG | | Name: | (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide | Formula: | C24 H34 N2 O | SMILES: | c1ccc(cc1)C43CC2(CC(C)(CC(C2)C3)C4)C(NC5CCC(N)CC5)=O | InChi: | InChI=1S/C24H34N2O/c1-22-11-17-12-23(14-22,18-5-3-2-4-6-18)16-24(13-17,15-22)21(27)26-20-9-7-19(25)8-10-20/h2-6,17,19-20H,7-16,25H2,1H3,(H,26,27)/t17-,19-,20-,22+,23+,24-/m0/s1 | Definition date: | 2018-12-06 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide |
|
| KNW | | Name: | (2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid | Formula: | C30 H30 Cl F N2 O7 | SMILES: | OC(=O)CCCN1C[CH](Oc2c(NC(=O)c3ccc(OCCCCc4cc(F)ccc4Cl)cc3)cccc12)C(O)=O | InChi: | InChI=1S/C30H30ClFN2O7/c31-23-14-11-21(32)17-20(23)5-1-2-16-40-22-12-9-19(10-13-22)29(37)33-24-6-3-7-25-28(24)41-26(30(38)39)18-34(25)15-4-8-27(35)36/h3,6-7,9-14,17,26H,1-2,4-5,8,15-16,18H2,(H,33,37)(H,35,36)(H,38,39)/t26-/m0/s1 | Synonyms: | ONO-2570366 | Definition date: | 2019-06-13 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid |
|
| KNZ | | Name: | (2~{S})-8-[[4-[4-[2,3-bis(fluoranyl)phenoxy]butoxy]-2-fluoranyl-phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid | Formula: | C30 H29 F3 N2 O8 | SMILES: | OC(=O)CCCN1C[CH](Oc2c(NC(=O)c3ccc(OCCCCOc4cccc(F)c4F)cc3F)cccc12)C(O)=O | InChi: | InChI=1S/C30H29F3N2O8/c31-20-6-3-9-24(27(20)33)42-15-2-1-14-41-18-11-12-19(21(32)16-18)29(38)34-22-7-4-8-23-28(22)43-25(30(39)40)17-35(23)13-5-10-26(36)37/h3-4,6-9,11-12,16,25H,1-2,5,10,13-15,17H2,(H,34,38)(H,36,37)(H,39,40)/t25-/m0/s1 | Synonyms: | ONO-2080365 | Definition date: | 2019-06-13 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2~{S})-8-[[4-[4-[2,3-bis(fluoranyl)phenoxy]butoxy]-2-fluoranyl-phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid |
|
| KO5 | | Name: | (2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid | Formula: | C31 H33 F N2 O7 | SMILES: | Cc1ccc(F)cc1CCCCOc2ccc(cc2)C(=O)Nc3cccc4N(CCCC(O)=O)C[CH](Oc34)C(O)=O | InChi: | InChI=1S/C31H33FN2O7/c1-20-10-13-23(32)18-22(20)6-2-3-17-40-24-14-11-21(12-15-24)30(37)33-25-7-4-8-26-29(25)41-27(31(38)39)19-34(26)16-5-9-28(35)36/h4,7-8,10-15,18,27H,2-3,5-6,9,16-17,19H2,1H3,(H,33,37)(H,35,36)(H,38,39)/t27-/m0/s1 | Synonyms: | ONO-2770372 | Definition date: | 2019-06-13 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid |
|
| L3D | | Name: | (2S)-tert-butoxy[4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl]acetic acid | Formula: | C27 H26 N2 O4 | SMILES: | Cc4c(C(C(=O)O)OC(C)(C)C)c(c1c3c2c(cc1)OCCc2ccn3)c5c(n4)cccc5 | InChi: | InChI=1S/C27H26N2O4/c1-15-21(25(26(30)31)33-27(2,3)4)23(17-7-5-6-8-19(17)29-15)18-9-10-20-22-16(12-14-32-20)11-13-28-24(18)22/h5-11,13,25H,12,14H2,1-4H3,(H,30,31)/t25-/m0/s1 | Definition date: | 2019-02-04 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2S)-tert-butoxy[4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl]acetic acid |
|
| L4A | | Name: | 2,5-bis(2-hydroxyethyl)-1,3-oxazole-4-carboxylic acid | Formula: | C8 H11 N O5 | SMILES: | c1(oc(c(n1)C(=O)O)CCO)CCO | InChi: | InChI=1S/C8H11NO5/c10-3-1-5-7(8(12)13)9-6(14-5)2-4-11/h10-11H,1-4H2,(H,12,13) | Synonyms: | Clavulanic Acid, opened form | Definition date: | 2019-02-06 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 2,5-bis(2-hydroxyethyl)-1,3-oxazole-4-carboxylic acid |
|
| LHQ | | Name: | ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] 2-(2,5-dihydrooxepin-7-yl)ethanethioate | Formula: | C29 H44 N7 O18 P3 S | SMILES: | CC(C)(CO[P](O)(=O)O[P](O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O[P](O)(O)=O)n2cnc3c(N)ncnc23)[CH](O)C(=O)NCCC(=O)NCCSC(=O)CC4=CCC=CCO4 | InChi: | InChI=1S/C29H44N7O18P3S/c1-29(2,24(40)27(41)32-8-7-19(37)31-9-11-58-20(38)12-17-6-4-3-5-10-49-17)14-51-57(47,48)54-56(45,46)50-13-18-23(53-55(42,43)44)22(39)28(52-18)36-16-35-21-25(30)33-15-34-26(21)36/h3,5-6,15-16,18,22-24,28,39-40H,4,7-14H2,1-2H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/t18-,22-,23-,24+,28-/m1/s1 | Definition date: | 2019-08-19 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] 2-(2,5-dihydrooxepin-7-yl)ethanethioate |
|
| LWQ | | Name: | ~{N}2,~{N}6-bis(1-methylquinolin-1-ium-3-yl)pyridine-2,6-dicarboxamide | Formula: | C27 H23 N5 O2 | SMILES: | C[n+]1cc(NC(=O)c2cccc(n2)C(=O)Nc3cc4ccccc4[n+](C)c3)cc5ccccc15 | InChi: | InChI=1S/C27H21N5O2/c1-31-16-20(14-18-8-3-5-12-24(18)31)28-26(33)22-10-7-11-23(30-22)27(34)29-21-15-19-9-4-6-13-25(19)32(2)17-21/h3-17H,1-2H3/p+2 | Definition date: | 2019-09-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | ~{N}2,~{N}6-bis(1-methylquinolin-1-ium-3-yl)pyridine-2,6-dicarboxamide |
|
| M5D | | Name: | 5-{(3R)-3-methyl-4-[(1R,2R)-2-methylcyclopropane-1-carbonyl]piperazin-1-yl}-3-(1-methyl-1H-pyrazol-4-yl)pyrazine-2-carbonitrile | Formula: | C19 H23 N7 O | SMILES: | c1(nc(cnc1C#N)N2CC(N(CC2)C(C3C(C3)C)=O)C)c4cnn(C)c4 | InChi: | InChI=1S/C19H23N7O/c1-12-6-15(12)19(27)26-5-4-25(10-13(26)2)17-9-21-16(7-20)18(23-17)14-8-22-24(3)11-14/h8-9,11-13,15H,4-6,10H2,1-3H3/t12-,13-,15-/m1/s1 | Definition date: | 2019-03-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 5-{(3R)-3-methyl-4-[(1R,2R)-2-methylcyclopropane-1-carbonyl]piperazin-1-yl}-3-(1-methyl-1H-pyrazol-4-yl)pyrazine-2-carbonitrile |
|
| M5V | | Name: | 4-[(1S,4S)-5-(3-chlorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(pyridin-3-yl)pyrimidine-5-carbonitrile | Formula: | C21 H17 Cl N6 | SMILES: | C1N(C2CC1N(C2)c3cc(ccc3)Cl)c5nc(c4cnccc4)ncc5C#N | InChi: | InChI=1S/C21H17ClN6/c22-16-4-1-5-17(7-16)27-12-19-8-18(27)13-28(19)21-15(9-23)11-25-20(26-21)14-3-2-6-24-10-14/h1-7,10-11,18-19H,8,12-13H2/t18-,19-/m0/s1 | Definition date: | 2019-03-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 4-[(1S,4S)-5-(3-chlorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(pyridin-3-yl)pyrimidine-5-carbonitrile |
|
| MLQ | | Name: | (2~{R})-2-[[6-[(2,4-dichlorophenyl)sulfonylamino]-1,3-benzothiazol-2-yl]sulfanyl]octanoic acid | Formula: | C21 H22 Cl2 N2 O4 S3 | SMILES: | CCCCCC[CH](Sc1sc2cc(N[S](=O)(=O)c3ccc(Cl)cc3Cl)ccc2n1)C(O)=O | InChi: | InChI=1S/C21H22Cl2N2O4S3/c1-2-3-4-5-6-17(20(26)27)30-21-24-16-9-8-14(12-18(16)31-21)25-32(28,29)19-10-7-13(22)11-15(19)23/h7-12,17,25H,2-6H2,1H3,(H,26,27)/t17-/m1/s1 | Definition date: | 2019-10-18 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2~{R})-2-[[6-[(2,4-dichlorophenyl)sulfonylamino]-1,3-benzothiazol-2-yl]sulfanyl]octanoic acid |
|
| N4W | | Name: | ~{N}1-[(~{S})-(3-chlorophenyl)-pyridin-2-yl-methyl]-4-methylsulfonyl-~{N}2-pyrimidin-2-yl-benzene-1,2-diamine | Formula: | C23 H20 Cl N5 O2 S | SMILES: | C[S](=O)(=O)c1ccc(N[CH](c2cccc(Cl)c2)c3ccccn3)c(Nc4ncccn4)c1 | InChi: | InChI=1S/C23H20ClN5O2S/c1-32(30,31)18-9-10-19(21(15-18)29-23-26-12-5-13-27-23)28-22(20-8-2-3-11-25-20)16-6-4-7-17(24)14-16/h2-15,22,28H,1H3,(H,26,27,29)/t22-/m0/s1 | Definition date: | 2019-11-12 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | ~{N}1-[(~{S})-(3-chlorophenyl)-pyridin-2-yl-methyl]-4-methylsulfonyl-~{N}2-pyrimidin-2-yl-benzene-1,2-diamine |
|
| N4Z | | Name: | ~{N}1-[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]-~{N}2-(4-methoxy-6-piperazin-1-yl-1,3,5-triazin-2-yl)-4-methylsulfonyl-benzene-1,2-diamine | Formula: | C28 H27 Cl F2 N8 O5 S | SMILES: | COc1nc(Nc2cc(ccc2N[CH](c3cccc4OC(F)(F)Oc34)c5ncccc5Cl)[S](C)(=O)=O)nc(n1)N6CCNCC6 | InChi: | InChI=1S/C28H27ClF2N8O5S/c1-42-27-37-25(36-26(38-27)39-13-11-32-12-14-39)35-20-15-16(45(2,40)41)8-9-19(20)34-22(23-18(29)6-4-10-33-23)17-5-3-7-21-24(17)44-28(30,31)43-21/h3-10,15,22,32,34H,11-14H2,1-2H3,(H,35,36,37,38)/t22-/m0/s1 | Definition date: | 2019-11-12 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | ~{N}1-[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]-~{N}2-(4-methoxy-6-piperazin-1-yl-1,3,5-triazin-2-yl)-4-methylsulfonyl-benzene-1,2-diamine |
|
| N5K | | Name: | 3-[(4-azanyl-6-methoxy-1,3,5-triazin-2-yl)amino]-4-[[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]amino]benzenesulfonamide | Formula: | C23 H19 Cl F2 N8 O5 S | SMILES: | COc1nc(N)nc(Nc2cc(ccc2N[CH](c3cccc4OC(F)(F)Oc34)c5ncccc5Cl)[S](N)(=O)=O)n1 | InChi: | InChI=1S/C23H19ClF2N8O5S/c1-37-22-33-20(27)32-21(34-22)31-15-10-11(40(28,35)36)7-8-14(15)30-17(18-13(24)5-3-9-29-18)12-4-2-6-16-19(12)39-23(25,26)38-16/h2-10,17,30H,1H3,(H2,28,35,36)(H3,27,31,32,33,34)/t17-/m0/s1 | Definition date: | 2019-11-12 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 3-[(4-azanyl-6-methoxy-1,3,5-triazin-2-yl)amino]-4-[[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]amino]benzenesulfonamide |
|
| OGM | | Name: | methyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate | Formula: | C10 H17 N3 O3 | SMILES: | COC(=O)NCCCCc1nc(CO)cn1 | InChi: | InChI=1S/C10H17N3O3/c1-16-10(15)11-5-3-2-4-9-12-6-8(7-14)13-9/h6,14H,2-5,7H2,1H3,(H,11,15)(H,12,13) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | methyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate |
|
| OGY | | Name: | [2-(3-phenylpropyl)-1H-imidazol-4-yl]methanol | Formula: | C13 H16 N2 O | SMILES: | c1(ccccc1)CCCc2ncc(CO)n2 | InChi: | InChI=1S/C13H16N2O/c16-10-12-9-14-13(15-12)8-4-7-11-5-2-1-3-6-11/h1-3,5-6,9,16H,4,7-8,10H2,(H,14,15) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | [2-(3-phenylpropyl)-1H-imidazol-4-yl]methanol |
|
| OH1 | | Name: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}benzamide | Formula: | C15 H19 N3 O2 | SMILES: | C(NC(c1ccccc1)=O)CCCc2ncc(CO)n2 | InChi: | InChI=1S/C15H19N3O2/c19-11-13-10-17-14(18-13)8-4-5-9-16-15(20)12-6-2-1-3-7-12/h1-3,6-7,10,19H,4-5,8-9,11H2,(H,16,20)(H,17,18) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}benzamide |
|
| OH4 | | Name: | {2-[(3S)-3-methoxy-3-phenylpropyl]-1H-imidazol-4-yl}methanol | Formula: | C14 H18 N2 O2 | SMILES: | n2c(CCC(c1ccccc1)OC)nc(c2)CO | InChi: | InChI=1S/C14H18N2O2/c1-18-13(11-5-3-2-4-6-11)7-8-14-15-9-12(10-17)16-14/h2-6,9,13,17H,7-8,10H2,1H3,(H,15,16)/t13-/m0/s1 | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | {2-[(3S)-3-methoxy-3-phenylpropyl]-1H-imidazol-4-yl}methanol |
|
| OH7 | | Name: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}acetamide | Formula: | C10 H17 N3 O2 | SMILES: | C(NC(C)=O)CCCc1ncc(CO)n1 | InChi: | InChI=1S/C10H17N3O2/c1-8(15)11-5-3-2-4-10-12-6-9(7-14)13-10/h6,14H,2-5,7H2,1H3,(H,11,15)(H,12,13) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}acetamide |
|
| OHG | | Name: | (2-methyl-1H-imidazol-4-yl)methanol | Formula: | C5 H8 N2 O | SMILES: | Cc1nc(cn1)CO | InChi: | InChI=1S/C5H8N2O/c1-4-6-2-5(3-8)7-4/h2,8H,3H2,1H3,(H,6,7) | Definition date: | 2019-06-25 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2-methyl-1H-imidazol-4-yl)methanol |
|
| OHJ | | Name: | (2-butyl-1H-imidazol-4-yl)methanol | Formula: | C8 H14 N2 O | SMILES: | C(c1cnc(CCCC)n1)O | InChi: | InChI=1S/C8H14N2O/c1-2-3-4-8-9-5-7(6-11)10-8/h5,11H,2-4,6H2,1H3,(H,9,10) | Definition date: | 2019-06-25 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2-butyl-1H-imidazol-4-yl)methanol |
|
| OHV | | Name: | benzyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate | Formula: | C16 H21 N3 O3 | SMILES: | C(CCCc1ncc(CO)n1)NC(=O)OCc2ccccc2 | InChi: | InChI=1S/C16H21N3O3/c20-11-14-10-18-15(19-14)8-4-5-9-17-16(21)22-12-13-6-2-1-3-7-13/h1-3,6-7,10,20H,4-5,8-9,11-12H2,(H,17,21)(H,18,19) | Definition date: | 2019-06-25 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | benzyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate |
|